REGULATION OF KERATINOCYTE SURVIVAL
REGULATION OF KERATINOCYTE SURVIVAL
批准号:
2896780
负责人:
ULRICH RODECK
金额:
$24.37万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2001-07-31
关键词:
RNase protection assay apoptosis biological signal transduction cellular oncology cysteine endopeptidases epidermal growth factor epithelium gene expression growth factor receptors human tissue immunoprecipitation keratinocyte northern blottings polymerase chain reaction protein tyrosine kinase tissue /cell culture western blottings
中文摘要
多细胞生物体的动态平衡在一定程度上取决于
细胞发生受控的细胞死亡或凋亡。相反,
诱导细胞凋亡的通路中断通常与
肿瘤的发展。目前,上皮细胞的分子调控
除了酪氨酸的激活外,人们对存活的了解很少
已知通过底物黏附的蛋白激酶(焦点黏附激酶)
是必需的。我们最近的研究表明,表皮的生长
因子受体(EGF-R)酪氨酸激酶类似地支持
人类正常角质形成细胞,但不是非上皮性正常人类细胞,
包括黑素细胞和成纤维细胞。建议的实验是
旨在定义将EGF-R激活连接到
上皮细胞存活的调控。在初步研究中,我们
观察到(I)脱离可加速EGF-R依赖的细胞凋亡
来自细胞外基质的角质形成细胞;(Ii)激活
EGF-R酪氨酸激酶部分与Ras/Raf/MEK的激活
角质形成细胞的凋亡需要信号级联反应来保护;
和(Iii)阻断EGF-R与下调抗-
凋亡的Bclxl分子。根据这些结果,我们假设
EGF-R酪氨酸磷酸化触发的信号转导通路
对角质形成细胞的存活至关重要,并且EGF-R的激活保护
正常角质形成细胞通过调节
BCL-2蛋白家族。为了检验这些假设,我们将:1)调查
EGF-R受体拮抗剂对成员基因和蛋白表达的影响
Bcl2蛋白家族(Bcl2、Bad、Bak、Bax)和死亡基因(ICE;
CPP32);2)通过强制过度表达来确定功能
Bc l-xl等相关Bc l-2家族成员在肿瘤发病中的作用
角质形成细胞凋亡和,3)检测EGF-R依赖的信号
Bc l-2存活和上调的信号转导途径
角质形成细胞中的XL。EGF-R依赖的相关分子表达
将使用已建立的免疫沉淀、Western和
Northern印迹、核糖核酸酶保护和RT-PCR方法。强迫基因
表达是使用先进的基因表达系统完成的,该系统
在永生化角质形成细胞中实现可调控的基因表达
并在正常角质形成细胞中表达。这些项目的长期目标是
研究旨在阐明与异常细胞相关的分子途径
上皮性恶性肿瘤的存活率。
英文摘要
Homeostasis of multicellular organisms depends in part on the ability
of cells to undergo controlled cell death or apoptosis. Conversely,
disruption of pathways that induce apoptosis is often associated with
tumor development. At present, the molecular control of epithelial cell
survival is poorly understood except that activation of a tyrosine
kinase (focal adhesion kinase) through substrate adhesion is known to
be required. Our recent studies indicate that the epidermal growth
factor-receptor (EGF-R) tyrosine kinase similarly supports survival of
human normal keratinocytes but not of non-epithelial normal human cells,
including melanocytes and fibroblasts. The proposed experiments are
designed to define molecular pathways linking EGF-R activation to
regulation of epithelial cell survival. In preliminary studies we
observed that (i) EGF-R-dependent apoptosis is accelerated by detachment
of keratinocytes from extracellular matrix; (ii) activation of the
tyrosine kinase moiety of the EGF-R and activation of the Ras/Raf/MEK
signaling cascade is required to protect keratinocytes from apoptosis;
and (iii) blocking EGF-R is associated with down-regulation of the anti-
apoptotic Bcl-xL molecule. Based on these results we hypothesize that
signaling pathways triggered by tyrosine phosphorylation of the EGF-R
are critical to keratinocyte survival and that EGF-R activation protects
normal keratinocytes from apoptosis via regulation of members of the
Bcl-2 protein family. To test these hypotheses we will: 1) investigate
the effect of EGF-R blockade on mRNA and protein expression of members
of the Bcl-2 protein family (Bcl-2, Bad, Bak, Bax) and death genes (ICE;
CPP32); 2) determine by forced overexpression the functional
contribution of Bcl-xL and other relevant Bcl-2 family members to
keratinocyte apoptosis and, 3) examine EGF-R-dependent signal
transduction pathways responsible for survival and up-regulation of Bcl-
xL in keratinocytes. EGF-R dependent expression of relevant molecules
will be assessed using established immunoprecipitation, Western and
Northern blotting, RNAse protection, and RT-PCR methods. Forced gene
expression is accomplished using advanced gene expression systems which
enable regulatable gene expression in the immortalized keratinocyte cell
line HaCaT and in normal keratinocytes. The long-term goal of these
studies is to elucidate molecular pathways relevant to aberrant cell
survival in epithelial malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monoclonal Antibody-based Prodrugs - Novel Tools for Cancer Therapy
-
批准号:8013862
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2010
-
负责人:ULRICH RODECK
-
依托单位:
Monoclonal Antibody-based Prodrugs - Novel Tools for Cancer Therapy
-
批准号:7788327
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2010
-
负责人:ULRICH RODECK
-
依托单位:
REGULATION OF KERATINOCYTE SURVIVAL
-
批准号:6478028
-
项目类别:
-
资助金额:$4.37万
-
财政年份:2001
-
负责人:ULRICH RODECK
-
依托单位:
TRANSFORMING GROWTH FACTOR-B EXPRESSION IN MELANOMA DEVELOPMENT AND PROGRESSION
-
批准号:6269086
-
项目类别:
-
资助金额:$14.65万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
REGULATION OF KERATINOCYTE SURVIVAL
-
批准号:6173877
-
项目类别:
-
资助金额:$25.1万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
TRANSFORMING GROWTH FACTOR-B EXPRESSION IN MELANOMA DEVELOPMENT AND PROGRESSION
-
批准号:6295884
-
项目类别:
-
资助金额:$14.65万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
Regulation of Keratinocyte Survival and Death
-
批准号:6866721
-
项目类别:
-
资助金额:$27.69万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
Regulation of Keratinocyte Survival and Death
-
批准号:6704216
-
项目类别:
-
资助金额:$27.69万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
Regulation of Keratinocyte Survival and Death
-
批准号:7025817
-
项目类别:
-
资助金额:$27.04万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
Regulation of Keratinocyte Survival and Death
-
批准号:6625666
-
项目类别:
-
资助金额:$34.8万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
REGULATION OF KERATINOCYTE SURVIVAL
-
批准号:2826919
-
项目类别:
-
资助金额:$25.65万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
Regulation of Keratinocyte Survival and Death
-
批准号:6477933
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1998
-
负责人:ULRICH RODECK
-
依托单位:
TRANSFORMING GROWTH FACTOR-B EXPRESSION IN MELANOMA DEVELOPMENT AND PROGRESSION
-
批准号:6236560
-
项目类别:
-
资助金额:$13.57万
-
财政年份:1997
-
负责人:ULRICH RODECK
-
依托单位:
TRANSFORMING GROWTH FACTOR-B EXPRESSION IN MELANOMA DEVELOPMENT AND PROGRESSION
-
批准号:6102027
-
项目类别:
-
资助金额:$15.91万
-
财政年份:--
-
负责人:ULRICH RODECK
-
依托单位:
TRANSFORMING GROWTH FACTOR-B EXPRESSION IN MELANOMA DEVELOPMENT AND PROGRESSION
-
批准号:5207065
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ULRICH RODECK
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: